人抗肝素PF4复合物抗体/HIT抗体(HIT)ELISA检测试剂盒现货供应 英文名称 HIT ELISA Kit 货号 XG-E988880 保存条件:2-8℃低温保存 保质期:6个月,所有试剂盒均提供批次。 试剂盒成分:酶标板,试剂,标准品等。 选型: 产品规格:96T/48T 96T指可以做94个标本-2个标准对照-84个样本 ...
PF4 蛋白本身具有独特的化学结构,并不容易被抗体识别,所以 HIT 患者虽然体内存在大量抗体,但可以在不接触肝素的情况下保持长时间不发病。 一旦这些人群因为医疗因素再次接受了肝素治疗,PF4 蛋白就会在肝素的牵线搭桥下,直接产生和抗体接触的机会,导致血...
英文名称:Human anti heparin PF4 complex antibody /HIT (HIT) ELISA Kit 产品规格:96T/48T(两种规格) 检测方法:酶免法/酶联免疫法(ELISA) 保存条件:2-8℃ 产品性状:液体盒装 产品价格:含税含运费,我们全程提供ELISA实验技术指导和ELISA试剂盒免费代测。
石油醚(for GC,用于环境分析)Petroleum ether CAS号:8032-32-4 质量规格:for GC,用于环境分析 人抗肝素PF4复合物抗体/HIT抗体-IgM(HIT)ELISA检测试剂盒 直销人 LRP1 / A2MR / CD91 (aa 786-1165) 人细胞裂解液 (阳性对照) (变性) 人 ICOSLG / B7-H2 / ICOSL / CD275 人细胞裂解液 (阳性对照)...
该领域既往研究已经表明 PF4 能结合肝素,一个名为 KKO 的 PF4 单克隆抗体可以诱发 HIT。 蔡征获得的晶体结构表明,KKO 结合的其实是四聚体 PF4 结构,这个结构的核心是类似肝素的多糖分子。 如果我们用糖葫芦来比喻一下,肝素这个多糖分子就是一根棍...
A prospective, blinded study of a PF4-dependent assay for HIT diagnosis.doi:10.1182/BLOOD.2020008195Bethany Samuelson BannowDeepti M. WaradCurtis G. JonesShannon M. PechauerBrian R. CurtisDaniel W. BougieRuchika SharmaDiane E. GrillMary W. Redman...
Generic Name:Human heparin associated antibody (HIT) ELISA Kit. Purpose This kit allows for thedetermination ofHITinHumanserum, and otherbiological fluids. Principle of the assay The kitassayHumanHITlevel in thesample,usePurifiedHumanHITantigen to coatmicrotiter plate wells, makesolid-phase antigen, ...
For research studies and protocols where a source of highly purified PF4 is necessary. Research Use Only. Order here.
CXCR3, known as CXCR3B. PF4 is the antigen in heparin-induced thrombocytopenia, an idiosyncratic autoimmune reaction to the administration of the anticoagulant heparin.PF4 autoantibodies have also been found in patients with thrombosis and features resembling HIT but no prior administration of heparin....
Anti-platelet factor 4/heparin complex antibodies (anti-PF4/heparin Ab) have been found to cause heparin-induced thrombocytopenia (HIT), a clinical syndrome thrombocytopenia and thrombosis. There is still controversy as to whether the presence of anti-PF4/heparin antibodies in hemodialysis patients ...